Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis

Molecular Carcinogenesis

Volumn 34, Issue 2, 2002, Pages 59-63

  Newell, Ken J ^a   Matrisian, Lynn M ^b   Driman, David K ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Colorectal cancer; Matrilysin; Matrix metalloproteinase 7; Ulcerative colitis

Indexed keywords

MATRILYSIN;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 7;

EID: 0036276519     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10049     Document Type: Article

References (42)

1. Changing views of the role of matrix metatloproteinases in metastasis
2. Tumor invasion and metastasis: An imbalance of positive and negative regulation
3. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
4. Association of matrilysin with recurrence and poor prognosis in human esophageal squamous cell carcinoma
5. Expression of collagenase-related genes in human lung or head and neck tumors
6. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen), in lung neoplasms: An immunohistochemical study
7. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas
8. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
9. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
10. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
11. Matrilysin expression in human prostate carcinoma
12. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
13. Matrix metalloproteinase-7 expression in gastric carcinoma
14. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas: Implications for vessel invasion and metastasis
15. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
16. Matrilysin is associated with progression of colorectal tumor
17. Matrilysin gene expression in sporadic and familial colorectal adenomas
18. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers
19. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
20. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
21. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis
22. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
23. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
24. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
25. Lessons from hereditary colorectal cancer
26. Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancer by comparative genomic hybridization
27. Molecular genetic profiles of colitis-associated neoplasms
28. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
29. Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability
30. DPC4 gene mutation in colitis-associated neoplasia
31. Matrix metalloproteinase levels are elevated in inflammatory bowel disease
32. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine
33. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12) and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcers
34. Enhanced expression of matrilysin, collagenase and stromelysin-1 in gastrointestinal ulcers
35. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
36. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
37. The influence of age on colonic epithelial cell proliferation
38. Rate and pattern of epithelial cell proliferation in ulcerative colitis
39. Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis
40. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells
41. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
42. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors